In AMD, TGF-β1 remained elevated after anti-vascular endothelial growth factor (VEGF) treatment, suggesting the regulation of TGF-β1 signaling was VEGF-independent [20]. The gene discussed is VEGFA; the disease is age-related macular degeneration.